Mustang™ Coronary Stent System Re-registered Successfully by SFDA
Shanghai, October 22th, 2012--MicroPort announced that the re-registration of Mustang™ Coronary Stent System has been approved by SFDA on September 13th2012.
Mustang™ Coronary Stent System is used with traditional PTCA (balloon angioplasty) to prevent stenosis and improve the function of coronary arteries. The design of large and small sine wave of Mustang™ provides better balanced strength and flexibility as well as conformability. Furthermore, the radial force has been further improved by the reinforceddesign of stiffing-ring structure.
Currently, there are over 80,000 units of Mustang™ Coronary Stent System havebeen soldsince the introduction of the product. Mustang™ has entered into many countries, such as China, Indonesia, Venezuela, Ecuador, Argentina, Uruguay, Brazil, Peru, Ukraine, Columbia, Philippines and Vietnam.
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.